Embattled STAP Cell Scientist Obokata to Retract Research Paper
By Japan Times,
The Japan Times
| 05. 28. 2014
OSAKA – Embattled scientist Haruko Obokata has agreed to retract one of two STAP cell research papers from the journal Nature, but maintains she will not retract the other one, her lawyer said Wednesday.
It is the first time that the 30-year-old researcher from the state-backed Riken Institute has agreed to have a paper retracted in connection with the high-profile study that quickly drew questions and allegations of misconduct.
Obokata, who led the study into the stimulus-triggered acquisition of pluripotency cells, and two other co-authors have given their consent to retract the paper, sources close to the matter said.
Of the three researchers, her lawyer said University of Yamanashi professor Teruhiko Wakayama is responsible for the paper Obokata has agreed to retract. He was engaged in all experiments, and Obokata wrote the paper under his guidance, lawyer Hideo Miki said.
She e-mailed the other main co-author, Yoshiki Sasai, deputy director of the Riken Center for Developmental Biology in Kobe, that she would have no problem if Wakayama wants to retract it, Miki said.
Both papers were published in the Jan...
Related Articles
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Robyn Vinter, The Guardian | 11.09.2025
A man going by the name “Rod Kissme” claims to have “very strong sperm”. It may seem like an eccentric boast for a Facebook profile page, but then this is no mundane corner of the internet. The group where Rod...